Upregulation of caveolin in multidrug resistant cancer cells: Functional implications

Advanced Drug Delivery Reviews

Volumn 49, Issue 3, 2001, Pages 317-323

  Lavie, Yaakov ^a   Fiucci, Giusy ^a   Liscovitch, Mordechai ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cancer; Caveolae; Caveolin; Cholesterol; Glucosylceramide; Multidrug resistance; Rafts; Transformation

Indexed keywords

BIOCHEMISTRY; BIOLOGICAL MEMBRANES; CELLS; CHEMOTHERAPY; CHOLESTEROL; PROTEINS; TUMORS;

CAVEOLINS;

PHARMACODYNAMICS;

CAVEOLIN 1; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; CHOLESTEROL; CYCLIN D1; CYTOTOXIC AGENT; GLUCOSYLCERAMIDE; GLYCOPROTEIN P; STEROL REGULATORY ELEMENT BINDING PROTEIN;

APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CARCINOGENESIS; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CHOLESTEROL TRANSPORT; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; DRUG TRANSPORT; HUMAN; MOLECULAR DYNAMICS; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TUMOR DIFFERENTIATION;

ANIMALS; CAVEOLINS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; UP-REGULATION;

EID: 0035963942     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00144-2     Document Type: Review

References (60)

1. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus
2. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts
3. Caveolin, a protein component of caveolae membrane coats
4. Caveolins, liquid-ordered domains, and signal transduction
5. The caveolae membrane system
6. Intracellular cholesterol transport
7. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles
8. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: Caveolin-2 is up-regulated in response to cell injury
9. Caveolin-1 expression and caveolae biogenesis during cell transdifferentiation in lung alveolar epithelial primary cultures
10. Caveolin-1 expression in Schwann cells
11. RNA genetics of breast cancer: Maspin as paradigm
12. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers
13. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines
14. Reduction of caveolin and caveolae in oncogenically transformed cells
15. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
16. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer
17. Reduction of caveolin 1 gene expression in lung carcinoma cell lines
18. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines
19. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade
20. Elevated expression of caveolin is associated with prostate and breast cancer
21. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain
22. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth
23. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane
24. How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture
25. Structure of the multidrug resistance P-glycoprotein
26. Molecular dissection of the human multidrug resistance P-glycoprotein
27. P-glycoprotein multidrug resistance and cancer
28. Export pumps for anionic conjugates encoded by MRP genes
29. Clinical drug resistance: The role of factors other than P-glycoprotein
30. Role of oncogenes in resistance and killing by cancer therapeutic agents
31. Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences
32. Accumulation of glucosylceramides in multidrug-resistant cancer cells
33. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells
34. Glucosylceramide: A marker for multiple-drug resistant cancers
35. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface
36. Separation of 'glycosphingolipid signaling domain' from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling
37. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells
38. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells
39. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells
40. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals
41. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance
42. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane
43. Intracellular cholesterol transport in synchronized human skin fibroblasts
44. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains
45. Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages
46. Plasma membrane caveolae mediate the efflux of cellular free cholesterol
47. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers
48. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol
49. VIP21/caveolin is a cholesterol-binding protein
50. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes
51. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol
52. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking
53. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae
54. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae
55. Multidrug resistance: A role for cholesterol efflux pathways?
56. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries
57. Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis
58. The cyclin D1 gene is transcriptionally repressed by caveolin-1
59. Reverse transformation of multidrug-resistant cells
60. Multidrug resistance and malignancy in human osteosarcoma